Categories AlphaGraphs, Earnings, Health Care

Key highlights from Abbott Laboratories (ABT) Q2 2023 earnings results

Abbott Laboratories (NYSE: ABT) reported second quarter 2023 earnings results today.

Net sales decreased 11.4% year-over-year to $10 billion. Organic sales growth, excluding COVID-19 tests, was 11.5%.

GAAP net income decreased 32% to $1.37 billion, or $0.78 per share, from last year. Adjusted EPS fell 24.5% to $1.08.

For full-year 2023, adjusted EPS is expected to range between $4.30-4.50.

Prior performance

Most Popular

Key metrics from Biogen’s (BIIB) Q4 2024 earnings results

Biogen Inc. (NASDAQ: BIIB) reported its fourth quarter 2024 earnings results today. Total revenue increased 3% year-over-year to $2.5 billion.   Net income attributable to Biogen Inc. was $266.8 million,

Important takeaways from Coca-Cola’s (KO) Q4 2024 earnings

The Coca-Cola Company (NYSE: KO) has wrapped up fiscal 2024 on an upbeat note, reporting stronger-than-expected results for the final quarter of the year. Encouraged by the growth in sales

Walt Disney (DIS): A look at the performance of the streaming business in 1Q25

Shares of The Walt Disney Company (NYSE: DIS) dropped 1% on Tuesday. The stock has gained 6% over the past three months. The company delivered top and bottom line growth

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top